Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|April 23, 2024
Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validationChristian Hobeika, Maxime Ronot, Boris Guiu, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 2, 2026
Diagnostic Impact of Two-Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective StudyTakashi Nishimura, Toshifumi Tada, Yasuaki Suzuki, et al.Journal of Gastroenterology|March 7, 2025
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept studyTomoko Aoki, Masatoshi Kudo, Naoshi Nishida, et al.Cancers|April 26, 2025
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off RegimenYudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Hayato Hikita, Yuki Tahata, et al.Journal of Gastroenterology|June 20, 2025
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosisNaoki Kawagishi, Goki Suda, Yuki Tahata, et al.Cancer Medicine|August 11, 2023
Effect of butyrate-producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumabKazuhiro Nouso, Shohei Shiota, Rio Fujita, et al.Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 29, 2026
Effect of Butyrate-Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and TremelimumabKazuhiro Nouso, Akiko Wakuta, Shohei Shiota, et al.Journal of Gastroenterology|March 7, 2025
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide surveyTakao Miwa, Mio Tsuruoka, Hajime Ueda, et al.Pageof 15